Qube Research & Technologies (QRT)
CNTX icon

Qube Research & Technologies (QRT)’s Context Therapeutics CNTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.9K Buy
+11,398
New +$26.6K ﹤0.01% 3241
2025
Q4 		– Sell
-82,111
Closed -$79.5K – 3717
2025
Q3 		$79.5K Sell
82,111
-24,668
-23% -$20K ﹤0.01% 3108
2025
Q2 		$70K Sell
106,779
-67,530
-39% -$48.6K ﹤0.01% 3095
2025
Q1 		$107K Sell
174,309
-148,529
-46% -$129K ﹤0.01% 2995
2024
Q4 		$339K Buy
322,838
+219,433
+212% +$380K ﹤0.01% 2651
2024
Q3 		$203K Buy
+103,405
New +$229K ﹤0.01% 2582

Other funds holding CNTX

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CNTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Context Therapeutics (CNTX) in Q1 2026: 11,398 shares worth $29.9K. The stake represents ﹤0.01% of the portfolio and ranks #3241 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CNTX as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in CNTX in Q3 2024 and has held it in 6 quarters since. The position peaked at $339K in Q4 2024. 59 funds tracked by Wall St. Rank hold CNTX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 11,398 shares of Context Therapeutics worth $29.9K as of Q1 2026.
  • Context Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Context Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3241 holding.
  • Qube Research & Technologies (QRT) first reported a position in Context Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • Qube Research & Technologies (QRT)'s Context Therapeutics position peaked at $339K in Q4 2024.
  • 59 funds tracked by Wall St. Rank held Context Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.